Bluespine
PrivateLast Round
Seed
Nov 13, 2024
Total Funding Raised
$7.2M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Bluespine operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in November 2024.
Bluespine is a fintech and healthtech company that provides an AI-driven claims cost reduction solution to help employers and healthcare organizations identify and prevent medical overbilling.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, Healthcare Analytics, Revenue Cycle
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bluespine Comparables
Compare Bluespine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CodaHx | 83% | |
| finHealth | 83% | |
| Alivia Analytics | 73% |
For institutional investors. Book with your work email.
Bluespine Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bluespine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Team8 | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 19, 2026
Open roles increased to 260, 8.6x the trailing average.
- Aug 21, 2026
Monthly visitors grew 78% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Bluespine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bluespine's valuation, stock price, and market status.
Is Bluespine a public or private company?
Bluespine is a private company.
What is the current stock price of Bluespine?
Bluespine is a private company, so its shares have no public market price. Caplight tracks Bluespine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bluespine worth (valuation)?
Valuation information for Bluespine is not publicly available.
Can I buy Bluespine stock?
Bluespine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bluespine's last funding round?
Bluespine's most recent funding round was Seed on November 13, 2024.
Who are the main investors in Bluespine?
Key investors in Bluespine include Team8.
Will Bluespine IPO soon?
No public IPO plans have been announced for Bluespine.
How can I track Bluespine secondary market activity?
Caplight tracks bids, offers, and trades in Bluespine's shares on secondary markets.